Amicus Therapeutics (NASDAQ:FOLD) Upgraded by StockNews.com to “Buy”
StockNews.com upgraded shares of Amicus Therapeutics (NASDAQ:FOLD – Free Report) from a hold rating to a buy rating in a report published on Monday. Several other equities analysts have also weighed in on the stock. Cantor Fitzgerald restated an overweight rating and set a $20.00 price target on shares of Amicus Therapeutics in a research […]
More Stories
Invesco Perpetual UK Smaller (IPU) to Issue Dividend of GBX 3.85 on December 6th
Invesco Perpetual UK Smaller (LON:IPU – Get Free Report) declared a dividend on Tuesday, October 8th, Upcoming.Co.Uk reports. Shareholders of...
Advance Auto Parts, Inc. (NYSE:AAP) Declares $0.25 Quarterly Dividend
Advance Auto Parts, Inc. (NYSE:AAP – Get Free Report) announced a quarterly dividend on Wednesday, August 7th, Wall Street Journal...
Taylor Wimpey plc (OTCMKTS:TWODY) to Issue Dividend of $0.56
Taylor Wimpey plc (OTCMKTS:TWODY – Get Free Report) announced a dividend on Wednesday, September 18th, NASDAQ reports. Shareholders of record...
Brookfield Asset Management Ltd. (NYSE:BAM) Given Consensus Recommendation of “Hold” by Brokerages
Shares of Brookfield Asset Management Ltd. (NYSE:BAM – Get Free Report) (TSE:BAM.A) have received an average recommendation of “Hold” from...
Insider Selling: Peyto Exploration & Development Corp. (TSE:PEY) Director Sells 1,070 Shares of Stock
Peyto Exploration & Development Corp. (TSE:PEY – Get Free Report) Director Stephen Jonathan Chetner sold 1,070 shares of the stock...
Insider Selling: Peyto Exploration & Development Corp. (TSE:PEY) Director Sells 1,070 Shares of Stock
Peyto Exploration & Development Corp. (TSE:PEY – Get Free Report) Director Stephen Jonathan Chetner sold 1,070 shares of the stock...